Knudsen, Beatrice S Jadhav, Alok Perry, Lindsey J Thagaard, Jeppe Deftereos, Georgios Ying, Jian Brintz, Ben J Zhang, Wei
Immunohistochemistry (IHC) is used to guide treatment decisions in multiple cancer types. For treatment with checkpoint inhibitors, programmed death ligand 1 (PD-L1) IHC is used as a companion diagnostic. However, the scoring of PD-L1 is complicated by its expression in cancer and immune cells. Separation of cancer and noncancer regions is needed t...
Hai, Josephine Meyer, Summer N Wong, Samantha L Li, Yueju Simmons, Elanee Miglioretti, Diana Fung, Maxwell A Kiuru, Maija
BackgroundS100A8 is a melanoma biomarker expressed in the melanoma-associated epidermal keratinocytes, but its diagnostic utility has not been compared with other biomarkers, including PRAME.ObjectivesTo compare the utility of S100A8 and PRAME immunohistochemistry (IHC) in the differential diagnosis of melanoma and naevi in a case-control study.Met...
Cai, Zhe Zuo, Linwei Hu, Fangfang You, Huiyan Lu, Xiangtong Liao, Shousheng Liu, Fanrong Li, Lixiang Huang, Wenyong
Published in
BMC pulmonary medicine
To present an unusual case of abnormal LCA expression and CD43 in SCLC and to review the reported literature to avoid potential diagnostic pitfalls. A 73-year-old male patient suffered from persistent back pain for more than one month. MRI revealed a compression fracture of the L1-L5 vertebra. A CT scan revealed multiple nodules and masses at the l...
Li, Zhen Li, Shike Li, Guangsen Yu, Tingting Zhang, Zhuo
Published in
Asian journal of surgery
Inaguma, Shingo Wang, Chengbo Ito, Sunao Ueki, Akane Lasota, Jerzy Czapiewski, Piotr Langfort, Renata Rys, Janusz Szpor, Joanna Waloszczyk, Piotr
...
Published in
Pathobiology
Introduction: Over the past decade, classifications using immune cell infiltration have been applied to many types of tumors; however, mesotheliomas have been less frequently evaluated. Methods: In this study, 60 well-characterized pleural mesotheliomas (PMs) were evaluated immunohistochemically for the characteristics of immune cells within tumor ...
Chen, Jianrong Zhang, Haiyong Li, Xiufang Hu, Mengjun Dai, Xiaomin
Published in
Journal of medical case reports
Giant cell tumor of soft tissue is a low malignant uncommon neoplasm, with histologic features and immunophenotype similar to its bone counterpart. Primary giant cell tumor of soft tissue in the thyroid gland is considered an exceedingly rare entity. We describe a case of primary thyroid giant cell tumor of soft tissue in a 69-year-old Chinese fema...
Klijanienko, Jerzy Masliah-Planchon, Julien Choussy, Olivier Rougier, Guillaume Vautrin, Antoine Dubray Lesnik, Maria Badois, Nathalie Ghanem, Wahib Klos, Jan Le Tourneau, Christophe
...
Published in
Acta Cytologica
Established FactsPoorly differentiated primary sarcomatoid parotid malignancies are exceptionally rare.Little information is available because these entities have not been studied completely using immunohistochemistry or molecular techniques.
Molière, Sébastien Lodi, Massimo Leblanc, Suzanne Gressel, Anne Mathelin, Carole Alpy, Fabien Chenard, Marie-Pierre Tomasetto, Catherine
Abstract Background Early hormone-positive breast cancers typically have favorable outcomes, yet long-term surveillance is crucial due to the risk of late recurrences. While many studies associate MMP-11 expression with poor prognosis in breast cancer, few focus on early-stage cases. This study explores MMP-11 as an early prognostic marker in hormo...
Kelada, Melad N Elagawany, Amany El Sekily, Nancy Mohamed El Mallah, Mona Abou Nazel, Maha W
Published in
Biological trace element research
Cisplatin is a potent antineoplastic drug that is used for treatment of many solid tumors. It has a wide range of adverse effects. Nephrotoxicity is the most common one of them. Platelet-rich plasma (PRP) is an autologous human plasma that activates the tissue regeneration through cell proliferation and differentiation. Study the role of PRP in ame...
Hwang, Inwoo Cho, Yunjoo Kang, So Young Kim, Deok Geun Ahn, Soomin Lee, Jeeyun Kim, Kyoung-Mee
Published in
Pathology, research and practice
The ARID1A gene is pivotal in chromatin remodeling and genomic integrity and is frequently mutated in various cancer types. ARID1A mutation is the second most frequently mutated tumor suppressor gene and has been suggested as a predictor of immunotherapeutic responsiveness in gastric carcinoma (GC). Despite its significance, the relationship among ...